首页> Vaccine> Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial.

Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial.

导出原文传递

翻译打印收藏纠错

第一作者： Carlos,Fierro

第一单位： Johnson County Clin-Trials (JCCT), 16400 College Blvd., Lenexa, KS 66219, USA.

作者： Carlos,Fierro ^[1] ; Heinz,Weidenthaler ^[2] ; Sanja,Vidojkovic ^[2] ; Darja,Schmidt ^[2] ; Zarina,Gafoor ^[3] ; Daria,Stroukova ^[2] ; Susan,Zwiers ^[3] ; Jutta,Müller ^[4] ; Ariane,Volkmann ^[5]

作者单位： Johnson County Clin-Trials (JCCT), 16400 College Blvd., Lenexa, KS 66219, USA. ^[1] Bavarian Nordic GmbH, Fraunhoferstrasse 13, 82152 Martinsried, Germany. ^[2] Bavarian Nordic Inc, 1005 Slater Road, Suite 101, Durham, NC 27703, USA. ^[3] Immunic AG, Lochhamer Schlag 21, 82166 Gräfelfing, Germany. ^[4] Bavarian Nordic GmbH, Fraunhoferstrasse 13, 82152 Martinsried, Germany. Electronic address: Ariane.Volkmann@bavarian-nordic.com. ^[5]

关键词 Alphavirus Eastern equine encephalitis virus (EEEV)Encephalitis MVA Vaccine Venezuelan equine encephalitis virus (VEEV)Western equine encephalitis virus (WEEV)

医学主题词人类(Humans);甲病毒属(Alphavirus);抗体, 中和(Antibodies, Neutralizing);抗体, 病毒(Antibodies, Viral);脑炎病毒, 委内瑞拉马(Encephalitis Virus, Venezuelan Equine);脑脊髓炎, 马(Encephalomyelitis, Equine);痘苗病毒(Vaccinia virus)

DOI 10.1016/j.vaccine.2024.03.011

PMID 38494412

发布时间 2025-08-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交